Form 4: CFO James Cox Exercises Options, Sells CWAN Stock
Insider Transaction Report
Clearwater Analytics CFO James Cox exercised stock options and subsequently sold shares, including those for tax obligations and under a pre-arranged trading plan.
Summary
- Clearwater Analytics Holdings, Inc. (CWAN) Chief Financial Officer, James S. Cox, engaged in multiple transactions on November 25, 2025.
- Mr. Cox exercised stock options to acquire 75,427 shares of Class A Common Stock at an exercise price of $4.4 per share.
- He disposed of 45,727 shares of Class A Common Stock at $22 per share to cover tax withholding obligations related to the option exercise; this was a mandated sale.
- An additional 29,700 shares of Class A Common Stock were sold at $22 per share pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2024.
- Following these transactions, Mr. Cox directly beneficially owns 333,983 shares of Class A Common Stock.
- He also holds 179,794 unexercised stock options.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions, including option exercise and subsequent sales for tax obligations and under a pre-arranged trading plan. While sales reduce direct ownership, the exercise of options at a lower price indicates prior confidence. The overall sentiment is neutral as these are common and often pre-planned events.
Positives
- The exercise of stock options by the CFO indicates prior confidence in the company's value, as the exercise price of $4.4 is significantly lower than the sale price of $22, resulting in a substantial personal gain.
Negatives
- A reduction in direct beneficial ownership by a key executive through the sale of 29,700 shares under a Rule 10b5-1 plan, even if pre-scheduled, can be perceived as a slight negative.
- The disposal of 45,727 shares to cover tax withholding, while non-discretionary, still reduces the CFO's direct equity stake in the company.
Future Outlook
na
Industry Context
na
Stakeholder Impact
- Shareholders: May view the reduction in direct ownership by a key executive as a minor negative, though the pre-planned nature of some sales and the tax-related sales mitigate concerns about discretionary selling. The overall impact on shareholder sentiment is likely minimal given the routine nature of such filings.
Key Dates
| Date | Description |
|---|---|
| 21-Jan-2020 | Vesting date for 180,000 stock option shares. |
| 02-Nov-2020 | Vesting date for 297,000 stock option shares. |
| 05-Mar-2021 | Vesting date for 105,750 stock option shares. |
| 01-Jan-2022 | Vesting date for 105,750 stock option shares. |
| 01-Jan-2023 | Vesting date for 105,750 stock option shares. |
| 01-Jan-2024 | Vesting date for 105,750 stock option shares. |
| March 11, 2024 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 11/25/2025 | Date of stock option exercise and subsequent sales of Class A Common Stock. |
| 11/26/2025 | Signature date of the reporting person's attorney-in-fact. |
| 05/20/2029 | Expiration date of the stock options. |
Recommendation
holdThis Form 4 details routine insider transactions by the CFO, including the exercise of stock options and subsequent sales for tax purposes and under a Rule 10b5-1 plan. Such transactions are common and typically do not signal a fundamental change in the company's prospects or warrant a change in investment recommendation. The sales were pre-planned or mandated, not discretionary, suggesting no new negative information. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an existing investment thesis.
Keywords
Clearwater Analytics, CWAN, Form 4, Insider Trading, Stock Options, CFO, James Cox, Equity Sales, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.